Skip to main content
. 2017 Feb 14;10(1):7. doi: 10.1186/s40413-016-0132-1

Table 3.

Evaluated parameters at 5 years in the 3 groups (mean, standard errors of means, 95% confidence intervals of the mean, and minimum and maximum values)

Mean Std. Error 95% Confidence Interval for Mean Minimum Maximum
Lower Bound Upper Bound
SMS Drugs 345.16 19.526 305.28 385.04 121 470
sSLIT 86.47 14.579 56.93 116.01 13 299
aSLIT 41.08 13.976 12.74 69.43 7 370
Total 146.28 15.532 115.49 177.08 7 470
MCh PD20 Drugs 925.48 152.588 613.86 1237.11 68 2380
sSLIT 1769.84 101.384 1564.42 1975.27 186 2443
aSLIT 1936.65 75.278 1783.98 2089.32 192 2394
Total 1581.13 75.241 1431.94 1730.32 68 2443
FEV1 Drugs 87.45 1.585 84.22 90.69 76 106
sSLIT 95.05 1.172 92.68 97.43 81 113
aSLIT 104.11 1.268 101.54 106.68 87 117
Total 95.99 1.000 94.01 97.97 76 117
BETA2 Drugs 5.13 1.226 2.63 7.63 0 19
sSLIT .32 .156 .00 .63 0 4
aSLIT .16 .099 −.04 .36 0 3
Total 1.67 .421 .84 2.50 0 19